Saa-1 and -2 gene expression levels were measured using qRT-PCR from skin, followed by measurement of SAA1/2 protein levels from serum using ELISA and finally the SAA1/2 protein levels were assayed using immunohistochemistry from PD patients’ skin. Here, SAA1 is linked to Parkinson disease.